Literature DB >> 6413653

Ganglioside-induced neuritogenesis: verification that gangliosides are the active agents, and comparison of molecular species.

M C Byrne, R W Ledeen, F J Roisen, G Yorke, J R Sclafani.   

Abstract

Gangliosides were previously reported to induce neuritogenesis in primary neuronal cultures and in some neurally derived cell lines. Because isolated gangliosides usually contain variable quantities of peptides, we investigated the possibility that neurite-stimulating activity could be caused by these contaminants. Ganglioside preparations from bovine brain and other sources were subjected to a three-step purification procedure that eliminated at least 95% of the contaminating peptides. These purified preparations retained their capacity to induce extensive neurite growth in neuro-2A murine neuroblastoma. Proteolytic digestion and a number of additional procedures were used to reduce residual contamination further without loss of activity. Several crude ganglioside samples had negative effects on neurite development until freed of their inhibitory factors, which were derived from the tissue and/or introduced during laboratory operations. This was particularly evident for bovine white matter gangliosides whose activity increased in proportion to peptide removal. When carefully purified, virtually all of 11 different gangliosides tested were highly active, with the possible exception of GM4, which demonstrated only moderate activity in a limited number of tests. All of the neutral glycolipids tested, as well as sulfatides and free sialic acid, were inactive.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6413653     DOI: 10.1111/j.1471-4159.1983.tb00814.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  17 in total

1.  Endogenous GM1 ganglioside of the plasma membrane promotes neuritogenesis by two mechanisms.

Authors:  Y Fang; G Wu; X Xie; Z H Lu; R W Ledeen
Journal:  Neurochem Res       Date:  2000-07       Impact factor: 3.996

Review 2.  In search of a solution to the sphinx-like riddle of GM1.

Authors:  Robert W Ledeen; Gusheng Wu
Journal:  Neurochem Res       Date:  2010-11-13       Impact factor: 3.996

3.  Glucosylceramide and the level of the glucosidase-stimulating proteins.

Authors:  S C Datta; N S Radin
Journal:  Lipids       Date:  1986-11       Impact factor: 1.880

4.  Fluid levity of the cell: Role of membrane lipid architecture in genetic sphingolipidoses.

Authors:  Ludovic D'Auria; Ernesto R Bongarzone
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

Review 5.  Secondary alterations of sphingolipid metabolism in lysosomal storage diseases.

Authors:  Alessandro Prinetti; Simona Prioni; Elena Chiricozzi; Edward H Schuchman; Vanna Chigorno; Sandro Sonnino
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

6.  Association of Src-family protein tyrosine kinases with sphingolipids in rat cerebellar granule cells differentiated in culture.

Authors:  A Prinetti; N Marano; S Prioni; V Chigorno; L Mauri; R Casellato; G Tettamanti; S Sonnino
Journal:  Glycoconj J       Date:  2000 Mar-Apr       Impact factor: 2.916

7.  Incorporation of exogenous ganglioside GM1 into neuroblastoma membranes: inhibition by calcium ion and dependence upon membrane protein.

Authors:  K C Leskawa; R E Erwin; A Leon; G Toffano; E L Hogan
Journal:  Neurochem Res       Date:  1989-06       Impact factor: 3.996

8.  Functional relationship between ammonia and gangliosides in brain.

Authors:  P Modi; B Sadasivudu; U Lakshminarayana; C R Murthy
Journal:  Neurochem Res       Date:  1994-03       Impact factor: 3.996

Review 9.  Is ganglioside GM1 effective in the treatment of stroke?

Authors:  S Braune
Journal:  Drugs Aging       Date:  1991-01       Impact factor: 3.923

10.  Influence of exogenous gangliosides on the three-dimensional sprouting of goldfish retinal explants in vitro.

Authors:  U Sonnentag; H Rösner; H Rahmann
Journal:  Neurochem Res       Date:  1992-11       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.